CROSS TALK BETWEEN THE IMMUNE AND THE CENTRAL NERVOUS SYSTEM-PART 2
This symposium will explore the mechanisms by which the immune system participates in the pathogenesis of MS, highlighting potential...
DONALD PATY LECTURE: MICROBIOME IN ADULTS AND PEDIATRICS
Following upon the discoveries that specific bacteria in the gut may modulate the onset of experimental autoimmune encephalomyelitis, an...
LATE BREAKING SCIENCE
Progress in understanding and treating multiple sclerosis evolves continuously and not always on a schedule aligned with scientific meeting...
ASSESSMENT AND TREATMENT OF SEXUAL DYSFUNCTION IN ONE VISIT
This workshop will describe the most common types of primary, secondary and tertiary sexual dysfunction in MS. The epidemiology of common...
THE EYES HAVE IT
Assessment of vision is a challenging but important component of the evaluation of patients with multiple sclerosis (MS), neuromyelitis...
Nabiximols, a Cannabis-Based Complex Botanical Mixture and MS Spasticity: How Does It Work?
Background: Nabiximols is a complex botanical mixture containing delta-9-tetrahydrocannibinol (THC), cannabidiol (CBD), other plant-derived...
Sources of Cannabis Information and Medical Guidance Among People with Multiple Sclerosis: Narcoms Survey Results
Background: The North American Research Committee on Multiple Sclerosis (NARCOMS) registry is a voluntary, self-report registry for people...
Arbaclofen Extended-Release for the Treatment of Spasticity in Multiple Sclerosis: A Randomized, Multi-Center, Placebo-Controlled Clinical Trial (Study OS440-3004)
Background: Arbaclofen, the active R-enantiomer of baclofen, a racemic g-aminobutyric acid-B (GABAB) receptor agonist, has been a mainstay...